Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 44

1.

Toso, a cell surface, specific regulator of Fas-induced apoptosis in T cells.

Hitoshi Y, Lorens J, Kitada SI, Fisher J, LaBarge M, Ring HZ, Francke U, Reed JC, Kinoshita S, Nolan GP.

Immunity. 1998 Apr;8(4):461-71.

2.

ARC, an inhibitor of apoptosis expressed in skeletal muscle and heart that interacts selectively with caspases.

Koseki T, Inohara N, Chen S, Núñez G.

Proc Natl Acad Sci U S A. 1998 Apr 28;95(9):5156-60.

3.

A single BIR domain of XIAP sufficient for inhibiting caspases.

Takahashi R, Deveraux Q, Tamm I, Welsh K, Assa-Munt N, Salvesen GS, Reed JC.

J Biol Chem. 1998 Apr 3;273(14):7787-90.

4.

Two CD95 (APO-1/Fas) signaling pathways.

Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ, Debatin KM, Krammer PH, Peter ME.

EMBO J. 1998 Mar 16;17(6):1675-87.

6.

Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade.

Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, Wang X.

Cell. 1997 Nov 14;91(4):479-89.

7.

The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases.

Roy N, Deveraux QL, Takahashi R, Salvesen GS, Reed JC.

EMBO J. 1997 Dec 1;16(23):6914-25.

8.

Bcl-x protects primary B cells against Fas-mediated apoptosis.

Schneider TJ, Grillot D, Foote LC, Núñez GE, Rothstein TL.

J Immunol. 1997 Nov 15;159(10):4834-9.

PMID:
9366408
9.
10.

Inhibition of death receptor signals by cellular FLIP.

Irmler M, Thome M, Hahne M, Schneider P, Hofmann K, Steiner V, Bodmer JL, Schröter M, Burns K, Mattmann C, Rimoldi D, French LE, Tschopp J.

Nature. 1997 Jul 10;388(6638):190-5.

PMID:
9217161
11.

I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1- and CD-95-induced apoptosis.

Hu S, Vincenz C, Ni J, Gentz R, Dixit VM.

J Biol Chem. 1997 Jul 11;272(28):17255-7.

12.

FLICE is activated by association with the CD95 death-inducing signaling complex (DISC).

Medema JP, Scaffidi C, Kischkel FC, Shevchenko A, Mann M, Krammer PH, Peter ME.

EMBO J. 1997 May 15;16(10):2794-804.

13.
14.

The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis.

Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD.

Science. 1997 Feb 21;275(5303):1132-6.

15.

Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked.

Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng TI, Jones DP, Wang X.

Science. 1997 Feb 21;275(5303):1129-32.

16.

Molecular ordering of the Fas-apoptotic pathway: the Fas/APO-1 protease Mch5 is a CrmA-inhibitable protease that activates multiple Ced-3/ICE-like cysteine proteases.

Srinivasula SM, Ahmad M, Fernandes-Alnemri T, Litwack G, Alnemri ES.

Proc Natl Acad Sci U S A. 1996 Dec 10;93(25):14486-91.

17.

Protection against Fas/APO-1- and tumor necrosis factor-mediated cell death by a novel protein, sentrin.

Okura T, Gong L, Kamitani T, Wada T, Okura I, Wei CF, Chang HM, Yeh ET.

J Immunol. 1996 Nov 15;157(10):4277-81.

PMID:
8906799
18.
19.

IL-4 induces Fas resistance in B cells.

Foote LC, Howard RG, Marshak-Rothstein A, Rothstein TL.

J Immunol. 1996 Oct 1;157(7):2749-53.

PMID:
8816375
20.

Intracellular signaling for inducible antigen receptor-mediated Fas resistance in B cells.

Foote LC, Schneider TJ, Fischer GM, Wang JK, Rasmussen B, Campbell KA, Lynch DH, Ju ST, Marshak-Rothstein A, Rothstein TL.

J Immunol. 1996 Sep 1;157(5):1878-85.

PMID:
8757305

Supplemental Content

Support Center